{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:18:35Z","timestamp":1787635115395,"version":"build-2736575974"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early-onset preeclampsia (EOPE) is a major cause of maternal and perinatal morbidity and is characterized by placental dysfunction, systemic endothelial injury, and hypertensive vascular stress. Because hypertensive disorders of pregnancy may also signal later maternal cardiovascular and cerebrovascular vulnerability, effective biomarkers for first-trimester risk assessment remain clinically important. Extrachromosomal circular DNA (eccDNA), a stable form of circulating cell-free DNA, has emerged as a potential source of disease-associated biomarkers. This study aimed to characterize first-trimester plasma eccDNA alterations associated with subsequent EOPE and to identify and validate a candidate circulating eccDNA marker for early risk assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A two-stage nested case\u2013control study was conducted within a prospective birth cohort. In the discovery stage, plasma samples collected at 11\u201313\u202fweeks of gestation from 5 women who subsequently developed EOPE and 5 matched normotensive controls were profiled by Circle-Seq to characterize genome-wide eccDNA alterations. Candidate eccDNAs were prioritized through differential abundance analysis and were further confirmed by outward PCR and Sanger sequencing. In the validation stage, the candidate selected marker was quantified by junction-specific qPCR in an independent cohort of 109 EOPE cases and 109 controls. Its potential predictive value was further evaluated alone and in combination with routine first-trimester clinical variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the exploratory discovery analysis, 410 nominally differentially abundant candidate eccDNAs were identified as a hypothesis-generating pool. Among these, GNA12\n                      <jats:sup>circle<\/jats:sup>\n                      (chr7:2876332\u20132,876,692) was prioritized and experimentally validated at the circular junction. In the independent validation cohort, plasma GNA12\n                      <jats:sup>circle<\/jats:sup>\n                      levels were significantly higher in women who later developed EOPE than in controls. When combined with routine first-trimester variables, GNA12\n                      <jats:sup>circle<\/jats:sup>\n                      improved predictive performance. The RF model showed the best overall cross-validated performance among the evaluated classifiers, with a mean held-out test-fold AUC of 0.843.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      First-trimester plasma eccDNA profiling revealed distinct alterations associated with subsequent EOPE, from which GNA12\n                      <jats:sup>circle<\/jats:sup>\n                      was identified and validated as a candidate circulating marker. These findings support further investigation of circulating eccDNA for early EOPE risk assessment in larger multicenter populations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1900036","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:22:52Z","timestamp":1787631772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery and validation of GNA12circle as a first-trimester plasma eccDNA marker for early-onset preeclampsia"],"prefix":"10.3389","volume":"17","author":[{"given":"Jin","family":"Wang","sequence":"first","affiliation":[{"name":"Prenatal Diagnosis Center, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Hou","sequence":"additional","affiliation":[{"name":"Prenatal Diagnosis Center, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Peng","sequence":"additional","affiliation":[{"name":"Prenatal Diagnosis Center, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Graduate School, Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntian","family":"Hao","sequence":"additional","affiliation":[{"name":"Prenatal Diagnosis Center, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Graduate School, Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[{"name":"Prenatal Diagnosis Center, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Graduate School, Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e071653","DOI":"10.1136\/bmj-2022-071653","article-title":"Hypertensive disorders of pregnancy","volume":"381","author":"Wu","year":"2023","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCRESAHA.124.325581","article-title":"Advances in our understanding of cardiovascular diseases after preeclampsia","volume":"136","author":"Countouris","year":"2025","journal-title":"Circ Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/j.ajog.2025.04.046","article-title":"Aspirin delays preeclampsia in women with chronic hypertension","volume":"233","author":"Bujold","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/HJH.0000000000003739","article-title":"Management of hypertensive disorders in pregnancy: a position statement of the European Society of Hypertension Working Group \u201chypertension in women.\u201d","volume":"42","author":"Thomopoulos","year":"2024","journal-title":"J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e2457828","DOI":"10.1001\/jamanetworkopen.2024.57828","article-title":"Prophylactic aspirin dose and preeclampsia","volume":"8","author":"Kupka","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/jamainternmed.2021.6373","article-title":"Association of antenatal diet and physical activity-based interventions with gestational weight gain and pregnancy outcomes: a systematic review and meta-analysis","volume":"182","author":"Teede","year":"2022","journal-title":"JAMA Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e022589","DOI":"10.1161\/JAHA.121.022589","article-title":"Mediterranean-style diet and risk of preeclampsia by race in the Boston birth cohort","volume":"11","author":"Minhas","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/HYPERTENSIONAHA.123.22584","article-title":"Prospective validation of first-trimester screening for preterm preeclampsia in nulliparous women (PREDICTION study)","volume":"81","author":"Guerby","year":"2024","journal-title":"Hypertension"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"244.e1","DOI":"10.1016\/j.ajog.2023.12.008","article-title":"Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women","volume":"231","author":"Becking","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41591-023-02774-x","article-title":"Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies","volume":"30","author":"Zhang","year":"2024","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jare.2025.10.005","article-title":"Beyond chromosomes: exploring the diverse functions of extrachromosomal circular DNA","volume":"85","author":"Chen","year":"2025","journal-title":"J Adv Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41392-022-01176-8","article-title":"Extrachromosomal circular DNA: biogenesis, structure, functions and diseases","volume":"7","author":"Yang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.1038\/s41467-024-53496-8","article-title":"Comparative analysis of methodologies for detecting extrachromosomal circular DNA","volume":"15","author":"Gao","year":"2024","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"11516","DOI":"10.3390\/ijms262311516","article-title":"Extrachromosomal circular DNA and transposable elements in type 2 diabetes","volume":"26","author":"Moya-Valera","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.18632\/aging.205388","article-title":"Identification and characterization of extrachromosomal circular DNA in age-related osteoporosis","volume":"15","author":"Zhu","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"jjaf237","DOI":"10.1093\/ecco-jcc\/jjaf237","article-title":"Inflammatory bowel disease is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity","author":"Petito","year":"2025","journal-title":"J Crohns Colitis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1128082","DOI":"10.3389\/fgene.2023.1128082","article-title":"Integrative profiling of extrachromosomal circular DNA in placenta and maternal plasma provides insights into the biology of fetal growth restriction and reveals potential biomarkers","volume":"14","author":"Lin","year":"2023","journal-title":"Front Genet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-024-02381-1","article-title":"Predicting gestational diabetes mellitus risk at 11-13 weeks\u2019 gestation: the role of extrachromosomal circular DNA","volume":"23","author":"Wang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1073\/pnas.1914949117","article-title":"Identification and characterization of extrachromosomal circular DNA in maternal plasma","volume":"117","author":"Sin","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"780779","DOI":"10.3389\/fimmu.2021.780779","article-title":"Identification and characterization of extrachromosomal circular DNA in human placentas with fetal growth restriction","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"152522","DOI":"10.1016\/j.bbrc.2025.152522","article-title":"Extrachromosomal circular DNA drives ferroptosis and immunity in trophoblasts via the STING pathway in preeclampsia","volume":"781","author":"Wang","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41467-018-03369-8","article-title":"Circular DNA elements of chromosomal origin are common in healthy human somatic tissue","volume":"9","author":"M\u00f8ller","year":"2018","journal-title":"Nat Commun"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s11658-023-00530-0","article-title":"Increased serum extrachromosomal circular DNA SORBS1circle level is associated with insulin resistance in patients with newly diagnosed type 2 diabetes mellitus","volume":"29","author":"Kong","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"101803","DOI":"10.1016\/j.ajogmf.2025.101803","article-title":"Performance of a first-trimester combined screening for preterm preeclampsia in the United States population using the fetal medicine foundation competing risks model","volume":"7","author":"Martins","year":"2025","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/HYPERTENSIONAHA.121.18421","article-title":"Optimal screening for preeclampsia in the first trimester of pregnancy","volume":"79","author":"Bujold","year":"2022","journal-title":"Hypertension"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"553.e1","DOI":"10.1016\/j.ajog.2023.05.015","article-title":"Noninvasive preeclampsia prediction using plasma cell-free RNA signatures","volume":"229","author":"Zhou","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41591-023-02510-5","article-title":"Cell-free DNA methylome analysis for early preeclampsia prediction","volume":"29","author":"De Borre","year":"2023","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/s41591-025-03509-w","article-title":"Preeclampsia risk prediction from prenatal cell-free DNA screening","volume":"31","author":"Adil","year":"2025","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.1038\/s41467-025-64215-2","article-title":"Maternal plasma cell-free RNA as a predictor of early and late-onset preeclampsia throughout pregnancy","volume":"16","author":"Castillo-Marco","year":"2025","journal-title":"Nat Commun"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/FM9.0000000000000215","article-title":"First trimester preeclampsia screening and prevention: perspective in Chinese mainland","volume":"6","author":"Liu","year":"2024","journal-title":"Matern Fetal Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e156070","DOI":"10.1172\/jci.insight.156070","article-title":"Effects of nucleases on cell-free extrachromosomal circular DNA","volume":"7","author":"Sin","year":"2022","journal-title":"JCI Insight"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1016\/j.csbj.2025.06.020","article-title":"Plasma cell-free extrachromosomal circular DNA is a molecular hallmark of preeclampsia","volume":"27","author":"Han","year":"2025","journal-title":"Comput Struct Biotechnol J"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"809425","DOI":"10.3389\/fcell.2022.809425","article-title":"G\u03b112 and G\u03b113: versatility in physiology and pathology","volume":"10","author":"Guo","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/ahg.12136","article-title":"Preeclampsia is associated with decreased methylation of the GNA12 promoter","volume":"80","author":"Ye","year":"2016","journal-title":"Ann Hum Genet"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"M111.012526","DOI":"10.1074\/mcp.M111.012526","article-title":"Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia","volume":"10","author":"Cox","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1345573","DOI":"10.3389\/fendo.2024.1345573","article-title":"Prediction model of preeclampsia using machine learning based methods: a population based cohort study in China","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/uog.24918","article-title":"Impact of replacing or adding pregnancy-associated plasma protein-a at 11-13\u202fweeks on screening for preterm pre-eclampsia","volume":"60","author":"Wah","year":"2022","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1900036\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:22:54Z","timestamp":1787631774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1900036\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":43,"alternative-id":["10.3389\/fneur.2026.1900036"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1900036","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1900036"}}